Record-Breaking Revenue and Adjusted EBITDA
Revenue increased 13.4% and adjusted EBITDA increased 15.2% relative to last year's third quarter, with a 26 basis point improvement in adjusted EBITDA margins.
Advanced Imaging Growth
Advanced imaging increased 13% on an aggregate basis and 9.9% on a same-center basis compared to last year's third quarter.
Digital Health Expansion
Digital health revenue increased 51.6% from last year's third quarter, with AI revenue growing 112%. The acquisition of iCAD contributed to this growth.
Reimbursement Rate Improvements
Successful in receiving rate increases from many commercial and capitated payers, with some capitated contracts converted to higher-paying fee-for-service relationships.
Strong Financial Liquidity
Cash balance was $804.7 million with a net debt to adjusted EBITDA ratio of approximately 1.0.
PET CT Volume Surge
PET CT volume increased 21.1% from last year's third quarter, driven by prostate imaging and amyloid brain studies for Alzheimer's.